Literature DB >> 4005426

In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools.

T H Carlson, T L Simon, A C Atencio.   

Abstract

It has recently been shown that antithrombin III (AT) distributes between plasma, a noncirculating vascular-associated pool and an extravascular pool in rabbit. Study of the in vivo behavior of autologous human 131I-AT demonstrates that in humans AT also distributes among three pools that are analogous to those found in rabbit. From the in vivo kinetic behavior of the 131I-labeled AT, the fractions of total-body AT in the plasma, noncirculating vascular-associated, and extravascular pools were calculated to be 0.393 +/- 0.015, 0.109 +/- 0.016, and 0.496 +/- 0.014, respectively. From three-exponential plasma radioactivity disappearance curves, an average plasma fractional catabolic rate, j3, of 0.576 +/- 0.034 day-1 was obtained for five healthy young men. This is almost identical to the result obtained if plasma 131I-AT disappearance is assumed to fit a two-exponential curve (0.546 +/- 0.038), where the constant C2 from *Ap(t) = C1e-a1t + C2e-a2t is assumed to be equal to 1 - C1. The fraction of the total vascular AT catabolized daily, j3.5, was calculated to be 0.457 +/- 0.034, and the fractional catabolic rate of total-body AT, jT, averaged 0.2271 +/- 0.0176. The results give further support to a model of in vivo behavior in which the vascular AT distributes between plasma and an endothelial receptor. Thus, the latter may serve to mediate activation of AT for its reaction with coagulation proteases and to mediate its entrance into the endothelial cell, where it is either transported to the extravascular fluids or is catabolized.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005426

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 3.  Clearance of thrombin in vivo: significance of alternative pathways.

Authors:  T H Carlson
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

4.  Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells.

Authors:  Feng-Pai Chou; Han Xu; Ming-Shyue Lee; Ya-Wen Chen; O X Durand Richards; Richard Swanson; Steven T Olson; Michael D Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-27       Impact factor: 4.249

5.  Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

Authors:  P N Hawkins; R Wootton; M B Pepys
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.

Authors:  Claudine Graf; Petra Wilgenbus; Sven Pagel; Jennifer Pott; Federico Marini; Sabine Reyda; Maki Kitano; Stephan Macher-Göppinger; Hartmut Weiler; Wolfram Ruf
Journal:  Sci Immunol       Date:  2019-09-20

7.  Acute normovolemic hemodilution does not reduce antithrombin concentration for cardiac surgery.

Authors:  Matthew Dean Linden; Mark Schneider; Wendy Naomi Erber
Journal:  J Thromb Thrombolysis       Date:  2004-06       Impact factor: 2.300

8.  Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients.

Authors:  J Constans; P Carles; A Boneu; J Arnaud; A E Tufenkji; M C Pujazon; C Tavera
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

9.  Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat.

Authors:  A A Horner
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

10.  Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.

Authors:  A I de Agostini; S C Watkins; H S Slayter; H Youssoufian; R D Rosenberg
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.